Does HPV-16 seropositivity correlate with T-cell distribution providing additional prognostic information in infected HNSCC patients?
It is widely accepted that infection with Human Papilloma Virus (HPV) confers better outcomes and survival rates in head and neck squamous cell carcinoma (HNSCC) patients (80% 5-year survival) compared with HPV-negative counterparts (50% 5-year survival),regardless of treatment modality. It is hypot...
Main Author: | Zahoor, Tosief |
---|---|
Published: |
University of Hull
2016
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.705737 |
Similar Items
-
The effect of HNSCC-derived soluble factors on the proliferation and function of immune cells
by: Smith, Joanne D.
Published: (2016) -
Genomic and epigenomic analysis of HPV positive and HPV negative head and neck squamous cell cancer
by: Lechner, M.
Published: (2012) -
The role of HPV E6 protein in the induction of autophagy
by: Almuhaini, Ghadir
Published: (2014) -
Novel biomarkers in the management of HPV-positive & -negative oropharyngeal carcinoma
by: Bolt, Robert
Published: (2016) -
Economic modelling assessment of cervical cancer screening and HPV vaccination in Brazil
by: Vanni, Tazio
Published: (2012)